Literature DB >> 16465184

In vitro models: research in physiology and pharmacology of the lower urinary tract.

Robert B Moreland1.   

Abstract

The physiology and pharmacology of the lower urinary tract has advanced based, in part, due to the in vitro assays that have facilitated this exploration. Such assays have led to the development of novel and selective molecules that have been used to characterize different receptor and enzyme systems in the larger context of in vivo pharmacology. These assays can be classified by sites of action of drugs into the following categories: receptors, effector enzymes and enzymes that terminate the responses. In this review, representative assays are presented based on our experience in male erectile dysfunction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16465184      PMCID: PMC1751497          DOI: 10.1038/sj.bjp.0706505

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  53 in total

1.  Characterization of ATP-sensitive potassium channels in human corporal smooth muscle cells.

Authors:  S W Lee; H Z Wang; G J Christ
Journal:  Int J Impot Res       Date:  1999-08       Impact factor: 2.896

2.  A cell-based microarrayed compound screening format for identifying agonists of G-protein-coupled receptors.

Authors:  Sujatha M Gopalakrishnan; Robert B Moreland; James L Kofron; Rosalind J Helfrich; Earl Gubbins; Jennifer McGowen; Jeffrey N Masters; Diana Donnelly-Roberts; Jorge D Brioni; David J Burns; Usha Warrior
Journal:  Anal Biochem       Date:  2003-10-15       Impact factor: 3.365

Review 3.  Making better drugs: Decision gates in non-clinical drug development.

Authors:  J Fred Pritchard; Malle Jurima-Romet; Mark L J Reimer; Elisabeth Mortimer; Brenda Rolfe; Mitchell N Cayen
Journal:  Nat Rev Drug Discov       Date:  2003-07       Impact factor: 84.694

4.  A-350619: a novel activator of soluble guanylyl cyclase.

Authors:  Loan N Miller; Masaki Nakane; Gin C Hsieh; Renjie Chang; Teodozyi Kolasa; Robert B Moreland; Jorge D Brioni
Journal:  Life Sci       Date:  2003-01-17       Impact factor: 5.037

Review 5.  Introduction to signal transduction: a primer for untangling the web of intracellular messengers.

Authors:  K M Eyster
Journal:  Biochem Pharmacol       Date:  1998-06-15       Impact factor: 5.858

6.  The expression of functional postsynaptic alpha2-adrenoceptors in the corpus cavernosum smooth muscle.

Authors:  S Gupta; R B Moreland; S Yang; C M Gallant; I Goldstein; A Traish
Journal:  Br J Pharmacol       Date:  1998-03       Impact factor: 8.739

7.  Sildenafil, a novel inhibitor of phosphodiesterase type 5 in human corpus cavernosum smooth muscle cells.

Authors:  R B Moreland; I Goldstein; A Traish
Journal:  Life Sci       Date:  1998       Impact factor: 5.037

8.  Functional prostaglandin E (EP) receptors in human penile corpus cavernosum.

Authors:  R B Moreland; N Kim; A Nehra; I Goldstein; A Traish
Journal:  Int J Impot Res       Date:  2003-10       Impact factor: 2.896

Review 9.  Predicting therapeutic value in the lead optimization phase of drug discovery.

Authors:  Terry Kenakin
Journal:  Nat Rev Drug Discov       Date:  2003-06       Impact factor: 84.694

10.  Expression of functional prostaglandin D (DP) receptors in human corpus cavernosum smooth muscle.

Authors:  R B Moreland; A Nehra; N N Kim; Kweon-Sik Min; H Albadawi; M T Watkins; I Goldstein; A M Traish
Journal:  Int J Impot Res       Date:  2002-12       Impact factor: 2.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.